Results 121 to 130 of about 16,545 (224)

Pathologic upstaging and survival outcomes for patients undergoing segmentectomy versus lobectomy in clinical stage T1cN0M0 non–small cell lung cancerCentral MessagePerspective

open access: yesJTCVS Open
Objectives: To assess the impact of the extent of surgical resection on overall survival in patients with clinical T1cN0M0 (cT1cN0M0) non–small cell lung cancer (NSCLC), with and without pathologic nodal upstaging (pN1+).
Ryan C. Jacobs, MD, MS   +11 more
doaj   +1 more source

Radiation Segmentectomy for Hepatocellular Carcinoma

open access: yesCurrent Oncology
The application of trans-arterial radioembolization (TARE) with Yttrium-90, historically a palliative treatment option for patients with advanced hepatocellular carcinoma (HCC), is evolving. Radiation segmentectomy (RADSEG), the segmental delivery of an ablative radiation dose, is a treatment option for patients with earlier-stage HCC.
Muhamad Serhal   +3 more
openaire   +3 more sources

Segmentectomies

open access: yesShanghai Chest, 2017
Anna E. Frick, Dirk Van Raemdonck
openaire   +1 more source

Nodal evaluation as the arbiter of oncologic equivalence: reassessing segmentectomy after CALGB 140503 and JCOG0802. [PDF]

open access: yesFront Oncol
Bazarbaev A   +5 more
europepmc   +1 more source

Development of Segmentectomy

open access: yesAdvances in Clinical Medicine, 2023
openaire   +1 more source

Evaluation of surgical approaches to segmentectomy in lung cancer: A survey study. [PDF]

open access: yesTurk Gogus Kalp Damar Cerrahisi Derg
Cansever L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy